Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


31.07.2017

1 Am J Ophthalmol
1 Anticancer Res
1 Br J Cancer
1 Br J Dermatol
1 Cancer Res
2 J Am Acad Dermatol
1 J Immunother
3 J Invest Dermatol
1 JAMA
1 Lancet Oncol
1 N Engl J Med
1 Oncol Rep
1 PLoS Genet


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Ophthalmol

  1. SEIBEL I, Riechardt AI, Heufelder J, Cordini D, et al
    Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
    Am J Ophthalmol. 2017;178:94-100.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. KIM YJ, Song SY, Kim W, Jeong SY, et al
    Feasibility of Postoperative Radiotherapy Using Conventional Fractionation for Lymph Node Metastasis from Cutaneous Melanoma.
    Anticancer Res. 2017;37:4239-4246.
    PubMed     Text format     Abstract available


    Br J Cancer

  3. BOIA-FERREIRA M, Basilio AB, Hamasaki AE, Matsubara FH, et al
    TCTP as a therapeutic target in melanoma treatment.
    Br J Cancer. 2017 Jul 27. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Br J Dermatol

  4. DIAS-SANTAGATA D, Selim MA, Su Y, Peng Y, et al
    KIT Mutations and CD117 Overexpression Are Markers of Better Progression-Free Survival in Vulvar Melanomas.
    Br J Dermatol. 2017 Jul 22. doi: 10.1111/bjd.15836.
    PubMed     Text format     Abstract available


    Cancer Res

  5. SEKTIOGLU IM, Carretero R, Bulbuc N, Bald T, et al
    Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells.
    Cancer Res. 2017;77:291-302.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  6. TANG H, Wu W, Fu S, Zhai S, et al
    Phosphodiesterase type 5 inhibitors and risk of melanoma: A meta-analysis.
    J Am Acad Dermatol. 2017 Jul 17. pii: S0190-9622(17)31662.
    PubMed     Text format     Abstract available

  7. KRAFT S, Fernandez-Figueras MT, Richarz NA, Flaherty KT, et al
    PDL1 expression in desmoplastic melanoma is associated with tumor aggressiveness and progression.
    J Am Acad Dermatol. 2017 Jul 17. pii: S0190-9622(17)31723.
    PubMed     Text format     Abstract available


    J Immunother

  8. REDDY SB, Possick JD, Kluger HM, Galan A, et al
    Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic Melanoma.
    J Immunother. 2017 Jul 21. doi: 10.1097/CJI.0000000000000181.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  9. ISHIDA Y, Otsuka A, Tanaka H, Levesque MP, et al
    HLA-A*26 is correlated with response to nivolumab in Japanese melanoma patients.
    J Invest Dermatol. 2017 Jul 20. pii: S0022-202X(17)31863.
    PubMed     Text format    

  10. CLARKE CA, McKinley M, Hurley S, Haile RW, et al
    Continued increase in melanoma incidence across all socioeconomic status groups in California, 1998-2012.
    J Invest Dermatol. 2017 Jul 20. pii: S0022-202X(17)31867.
    PubMed     Text format     Abstract available

  11. GASSENMAIER M, Eigentler TK, Keim U, Goebeler M, et al
    Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry.
    J Invest Dermatol. 2017 Jul 20. pii: S0022-202X(17)31871.
    PubMed     Text format     Abstract available


    JAMA

  12. SLOMSKI A
    Combination Therapy Shrinks Melanoma Brain Metastases.
    JAMA. 2017;318:323.
    PubMed     Text format    


    Lancet Oncol

  13. LONG GV, Atkinson V, Cebon JS, Jameson MB, et al
    Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial.
    Lancet Oncol. 2017 Jul 17. pii: S1470-2045(17)30428.
    PubMed     Text format     Abstract available


    N Engl J Med

  14. COSTELLO CM, Pittelkow MR, Mangold AR
    Acral Melanoma and Mechanical Stress on the Plantar Surface of the Foot.
    N Engl J Med. 2017;377:395-396.
    PubMed     Text format    


    Oncol Rep

  15. MENG F, Zhang Y, Li X, Wang J, et al
    Clinical significance of miR-138 in patients with malignant melanoma through targeting of PDK1 in the PI3K/AKT autophagy signaling pathway.
    Oncol Rep. 2017 Jul 19. doi: 10.3892/or.2017.5838.
    PubMed     Text format     Abstract available


    PLoS Genet

  16. RUIZ R, Jahid S, Harris M, Marzese DM, et al
    The RhoJ-BAD signaling network: An Achilles' heel for BRAF mutant melanomas.
    PLoS Genet. 2017;13:e1006913.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: